Analysis: How Common Is Metabolic Syndrome in Patients With PsA?
Assessing the prevalence of metabolic syndrome in patients with PsA remains a challenge because the definition varies across studies, according to the authors.
Stay updated with breaking news from Ancer Prostate . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Assessing the prevalence of metabolic syndrome in patients with PsA remains a challenge because the definition varies across studies, according to the authors.
Relugolix (Orgovyx) offers an oral formulation of androgen deprivation therapy (ADT) for use in men with advanced hormone-sensitive prostate cancer.
A remarkable reduction in bowel and urinary side effects was reported when MRI was used instead of CT to guide stereotactic body radiotherapy for localized prostate cancer.
Water vapor ablation therapy was found to improve urination complaints even in men with "enormous" prostate glands.
A novel screening tool was able to accurately identify people with high vs low lifetime risks of developing metastatic prostate cancer or dying from the disease across diverse groups of men.